Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Elizabeth Blair

Concepts (341)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell
19
2019
1043
1.690
Why?
Head and Neck Neoplasms
24
2017
1013
1.630
Why?
Salivary Gland Neoplasms
5
2019
62
1.460
Why?
Carcinoma, Mucoepidermoid
2
2019
17
1.440
Why?
Chemoradiotherapy
14
2022
295
1.120
Why?
Neoplasm Recurrence, Local
12
2019
1204
0.980
Why?
Oropharyngeal Neoplasms
6
2022
120
0.900
Why?
Antineoplastic Combined Chemotherapy Protocols
19
2022
2356
0.890
Why?
Mouth Neoplasms
7
2018
181
0.780
Why?
Paranasal Sinus Diseases
2
2018
23
0.780
Why?
Gene Rearrangement
2
2019
171
0.760
Why?
Papillomavirus Infections
5
2022
225
0.740
Why?
Neoplasm Grading
1
2019
333
0.690
Why?
Laryngeal Diseases
2
2015
17
0.680
Why?
Nose Diseases
1
2017
10
0.680
Why?
Nose Neoplasms
1
2017
31
0.680
Why?
Maxillary Sinus
2
2018
26
0.650
Why?
Nasal Cavity
1
2017
101
0.640
Why?
Trans-Activators
1
2019
449
0.610
Why?
Paranasal Sinus Neoplasms
1
2016
24
0.600
Why?
Aspergillosis
1
2016
46
0.590
Why?
Cementoma
1
2015
2
0.590
Why?
Mandibular Neoplasms
1
2015
25
0.570
Why?
Sarcoidosis
1
2015
91
0.540
Why?
Papillomaviridae
4
2022
147
0.540
Why?
Laryngeal Neoplasms
5
2017
87
0.530
Why?
Sjogren's Syndrome
3
2009
29
0.500
Why?
Salivary Glands, Minor
2
2009
10
0.490
Why?
Middle Aged
43
2022
25918
0.460
Why?
Aged, 80 and over
21
2020
6680
0.450
Why?
Otolaryngology
1
2012
40
0.440
Why?
Airway Management
1
2012
38
0.440
Why?
Female
51
2022
45495
0.420
Why?
Humans
68
2022
85326
0.410
Why?
Adult
39
2022
26372
0.400
Why?
Placenta
1
2011
205
0.390
Why?
Anesthesiology
1
2012
164
0.380
Why?
Aged
34
2020
18815
0.380
Why?
Quinazolines
4
2012
220
0.380
Why?
Induction Chemotherapy
6
2022
143
0.370
Why?
Male
48
2022
42565
0.360
Why?
Disease-Free Survival
15
2020
1209
0.350
Why?
Neck
2
2020
98
0.330
Why?
Head
2
2020
126
0.320
Why?
Hydroxyurea
9
2012
231
0.320
Why?
Radiotherapy, Intensity-Modulated
5
2016
182
0.310
Why?
Clinical Competence
1
2012
726
0.300
Why?
Radiotherapy Dosage
11
2020
485
0.290
Why?
Warts
2
2019
11
0.290
Why?
Fluorouracil
9
2012
567
0.280
Why?
Tongue Neoplasms
4
2018
52
0.280
Why?
Nasopharyngeal Neoplasms
2
2016
44
0.280
Why?
Diagnosis, Differential
4
2017
1612
0.270
Why?
Alphapapillomavirus
2
2021
43
0.250
Why?
Treatment Outcome
17
2022
8047
0.250
Why?
Antineoplastic Agents
6
2012
2379
0.250
Why?
Neoplasm Staging
12
2016
1953
0.230
Why?
Paclitaxel
5
2022
464
0.230
Why?
Laryngostenosis
1
2021
14
0.220
Why?
Tracheal Stenosis
1
2021
23
0.220
Why?
Carcinoma
2
2016
444
0.220
Why?
Drug Monitoring
1
2022
121
0.210
Why?
Carcinoma, Papillary, Follicular
1
2020
11
0.210
Why?
DNA, Viral
1
2022
281
0.210
Why?
Respiratory System
1
2021
115
0.210
Why?
In Situ Hybridization, Fluorescence
2
2019
362
0.200
Why?
ras Proteins
1
2020
133
0.200
Why?
Smoking
3
2014
572
0.200
Why?
Follow-Up Studies
13
2019
3896
0.190
Why?
Proto-Oncogene Proteins B-raf
1
2020
137
0.190
Why?
Lymph Nodes
2
2016
540
0.190
Why?
Thyroid Neoplasms
2
2020
442
0.190
Why?
Risk Factors
8
2019
5511
0.190
Why?
Arteries
1
2020
192
0.190
Why?
Heterocyclic Compounds
1
2019
16
0.190
Why?
Retrospective Studies
15
2018
7983
0.190
Why?
Practice Guidelines as Topic
2
2017
1096
0.190
Why?
Immunologic Deficiency Syndromes
1
2019
45
0.190
Why?
Radiation Dosage
1
2020
232
0.190
Why?
Young Adult
6
2022
6100
0.180
Why?
Bone Cysts, Aneurysmal
1
2018
7
0.180
Why?
Receptors, CXCR4
1
2019
41
0.180
Why?
Lip
2
2009
16
0.180
Why?
Prognosis
9
2022
3751
0.180
Why?
Combined Modality Therapy
9
2016
1693
0.180
Why?
Orthodontic Appliances
1
2018
8
0.180
Why?
Dental Alloys
1
2018
7
0.180
Why?
Precancerous Conditions
2
2016
208
0.180
Why?
Deglutition
3
2020
70
0.180
Why?
Ubiquitin Thiolesterase
1
2018
57
0.180
Why?
Inflammation
2
2017
865
0.170
Why?
Glottis
1
2017
12
0.170
Why?
Child
6
2019
6954
0.170
Why?
Bone Marrow
1
2019
425
0.160
Why?
Adolescent
7
2022
9323
0.160
Why?
Hypopharyngeal Neoplasms
2
2011
15
0.160
Why?
Life Style
1
2018
194
0.160
Why?
Fibrosis
1
2017
200
0.160
Why?
Prospective Studies
7
2022
4179
0.150
Why?
Transcriptome
1
2020
541
0.150
Why?
Fibroma, Ossifying
1
2015
5
0.150
Why?
Neoplasm Invasiveness
3
2016
537
0.150
Why?
Anticarcinogenic Agents
1
2016
73
0.150
Why?
Time Factors
4
2019
5561
0.140
Why?
Guideline Adherence
1
2017
231
0.140
Why?
Premedication
1
1995
58
0.140
Why?
Pleural Neoplasms
1
2017
183
0.140
Why?
Gene Expression Regulation, Neoplastic
1
2020
1212
0.140
Why?
Cerebellopontine Angle
1
1994
7
0.140
Why?
Ulnar Nerve
1
1994
6
0.140
Why?
Neuroma, Acoustic
1
1994
16
0.130
Why?
Tumor Virus Infections
1
2014
82
0.130
Why?
Predictive Value of Tests
1
2019
1783
0.130
Why?
Maximum Tolerated Dose
3
2012
272
0.130
Why?
Neuromuscular Blocking Agents
1
1994
35
0.130
Why?
Leukoplakia, Oral
1
2013
9
0.130
Why?
Facial Nerve
1
1994
35
0.130
Why?
Aminolevulinic Acid
1
2013
22
0.130
Why?
Photosensitizing Agents
1
2013
47
0.130
Why?
Anti-Bacterial Agents
2
1999
834
0.120
Why?
Carboplatin
3
2022
274
0.120
Why?
Biopsy
4
2009
1196
0.120
Why?
Monitoring, Intraoperative
1
1994
147
0.120
Why?
Mouth
2
2011
54
0.120
Why?
Photochemotherapy
1
2013
99
0.120
Why?
Pain
1
2015
375
0.120
Why?
Radiation-Sensitizing Agents
1
2012
102
0.120
Why?
Education, Medical, Graduate
1
2016
352
0.110
Why?
Deglutition Disorders
2
2011
90
0.110
Why?
Radiotherapy
2
2011
342
0.110
Why?
Lymph Node Excision
1
2013
212
0.110
Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.110
Why?
Chemotherapy, Adjuvant
5
2012
472
0.110
Why?
Research Design
2
2013
584
0.110
Why?
Survival Analysis
5
2018
1601
0.110
Why?
Organ Preservation
1
2011
75
0.110
Why?
Tracheotomy
1
2011
20
0.110
Why?
Protein Kinase Inhibitors
1
2016
574
0.110
Why?
Survival Rate
4
2019
1938
0.100
Why?
Speech
1
2010
72
0.100
Why?
Brain Diseases
1
2011
190
0.100
Why?
Vocal Cords
1
2009
19
0.100
Why?
Genetic Predisposition to Disease
1
2019
2251
0.100
Why?
Agammaglobulinemia
1
2010
21
0.100
Why?
Airway Obstruction
1
2011
118
0.100
Why?
Developmental Disabilities
1
2011
193
0.100
Why?
Quality of Life
3
2012
1413
0.100
Why?
Emergency Medical Services
1
2012
188
0.100
Why?
Vascular Endothelial Growth Factor A
2
2009
390
0.090
Why?
Kaplan-Meier Estimate
4
2013
907
0.090
Why?
Radiotherapy, High-Energy
1
2008
50
0.090
Why?
Cohort Studies
5
2018
2764
0.090
Why?
Confidence Intervals
4
2018
236
0.090
Why?
Enteral Nutrition
2
2020
108
0.090
Why?
Neck Dissection
4
2010
72
0.090
Why?
Myelitis, Transverse
1
2008
10
0.090
Why?
Submandibular Gland Diseases
1
2008
9
0.090
Why?
Military Personnel
1
2009
78
0.090
Why?
Neoplasms, Second Primary
1
2011
251
0.090
Why?
Genomics
1
2014
666
0.090
Why?
United States
6
2018
6541
0.090
Why?
Neuromyelitis Optica
1
2008
18
0.090
Why?
Neoadjuvant Therapy
2
2012
286
0.090
Why?
Skin
1
2012
560
0.090
Why?
Aortic Aneurysm
1
1988
81
0.090
Why?
Fatal Outcome
2
2019
309
0.080
Why?
Taxoids
1
2007
132
0.080
Why?
Risk Assessment
5
2016
2305
0.080
Why?
Sinus Thrombosis, Intracranial
1
2006
11
0.080
Why?
DNA
1
2012
1306
0.080
Why?
Tinnitus
1
2006
20
0.080
Why?
Headache
1
2006
71
0.080
Why?
Incidence
3
2018
1667
0.070
Why?
Prodrugs
2
1996
48
0.070
Why?
Drug Administration Schedule
4
2016
973
0.070
Why?
Dose-Response Relationship, Drug
3
2019
2104
0.070
Why?
Infant, Newborn
1
2011
2478
0.070
Why?
Antibodies, Monoclonal
2
2010
1534
0.070
Why?
Drug Therapy, Combination
3
1999
1001
0.070
Why?
Cisplatin
2
2022
585
0.070
Why?
Gastroesophageal Reflux
2
2009
127
0.070
Why?
Pregnancy
1
2011
2911
0.070
Why?
Adenocarcinoma
1
2011
1205
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2017
102
0.060
Why?
Radiotherapy, Adjuvant
3
2010
311
0.060
Why?
Internship and Residency
1
2012
933
0.060
Why?
Tomography, X-Ray Computed
2
2011
2601
0.060
Why?
Remission Induction
2
2016
717
0.060
Why?
Retreatment
2
2012
107
0.060
Why?
Pulmonary Surgical Procedures
1
2021
8
0.060
Why?
Immunohistochemistry
3
2017
1836
0.060
Why?
Alcohol Drinking
2
2018
276
0.060
Why?
Receptor, Endothelin A
1
2021
24
0.060
Why?
Gene Expression Profiling
2
2020
1393
0.060
Why?
Clinical Trials, Phase II as Topic
2
2013
174
0.060
Why?
Endothelial Growth Factors
1
2001
60
0.050
Why?
Respiratory Function Tests
1
2021
148
0.050
Why?
Lymphokines
1
2001
115
0.050
Why?
Constriction, Pathologic
1
2021
216
0.050
Why?
Periodontal Diseases
1
2000
10
0.050
Why?
Radiography
2
2014
882
0.050
Why?
Bronchoscopy
1
2021
151
0.050
Why?
Lymphoid Tissue
1
2000
63
0.050
Why?
Hyperplasia
1
2000
159
0.050
Why?
Clindamycin
2
1999
16
0.050
Why?
Disease Progression
2
2017
1488
0.050
Why?
Antibodies, Monoclonal, Humanized
3
2011
965
0.050
Why?
Cefuroxime
2
1996
3
0.050
Why?
Tonsillectomy
1
1999
28
0.050
Why?
Carcinoma, Papillary
1
2001
182
0.050
Why?
Feasibility Studies
1
2022
770
0.050
Why?
Benzylamines
1
2019
16
0.050
Why?
Neoplasms, Squamous Cell
1
2019
19
0.050
Why?
Patient-Centered Care
1
2021
191
0.050
Why?
Aortic Rupture
2
1990
53
0.050
Why?
Bone Marrow Examination
1
2019
53
0.050
Why?
Patient Care Team
1
2021
280
0.050
Why?
Antibiotic Prophylaxis
1
1999
83
0.050
Why?
Primary Myelofibrosis
1
2019
53
0.050
Why?
Evidence-Based Medicine
1
2021
458
0.040
Why?
Oral Health
1
2018
10
0.040
Why?
Double-Blind Method
3
2016
1916
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
11
0.040
Why?
Myoepithelioma
1
2017
11
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2017
24
0.040
Why?
Metals
1
2018
93
0.040
Why?
Laryngectomy
1
2017
26
0.040
Why?
Surgical Wound Infection
2
1999
190
0.040
Why?
Parotid Gland
1
2017
35
0.040
Why?
Multivariate Analysis
2
2011
1026
0.040
Why?
Statistics, Nonparametric
2
2009
326
0.040
Why?
Adenocarcinoma, Clear Cell
1
2017
59
0.040
Why?
Oncogene Proteins, Fusion
1
2017
124
0.040
Why?
Probability
2
2008
362
0.040
Why?
Otitis Media
1
1996
15
0.040
Why?
Translocation, Genetic
1
2017
263
0.040
Why?
Mutation
2
2020
3900
0.040
Why?
Loss of Heterozygosity
1
2016
88
0.040
Why?
Otitis Media with Effusion
1
1995
7
0.040
Why?
Pyrazoles
1
2017
169
0.040
Why?
Analgesics, Opioid
1
2020
386
0.040
Why?
Cutaneous Fistula
1
1995
13
0.040
Why?
Cellulitis
1
1995
22
0.040
Why?
Cephalosporins
1
1995
43
0.040
Why?
Dissection
1
1995
48
0.040
Why?
Pyridines
1
2017
313
0.040
Why?
Human papillomavirus 18
1
2014
16
0.030
Why?
Magnetic Resonance Imaging
3
2017
3318
0.030
Why?
Costs and Cost Analysis
1
1995
154
0.030
Why?
Human papillomavirus 16
1
2014
38
0.030
Why?
Protein Interaction Maps
1
2014
50
0.030
Why?
Drug Costs
1
1995
63
0.030
Why?
Sex Factors
1
2018
1098
0.030
Why?
Hospital Costs
1
1995
104
0.030
Why?
Administration, Oral
1
2016
730
0.030
Why?
Electromyography
1
1994
182
0.030
Why?
Amoxicillin-Potassium Clavulanate Combination
3
1999
4
0.030
Why?
Clavulanic Acids
3
1999
4
0.030
Why?
Drug Resistance, Neoplasm
1
2017
581
0.030
Why?
Societies, Medical
1
2017
580
0.030
Why?
Amoxicillin
3
1999
14
0.030
Why?
DNA Copy Number Variations
1
2014
182
0.030
Why?
Multicenter Studies as Topic
1
2013
156
0.030
Why?
Electric Stimulation
1
1994
378
0.030
Why?
Rabbits
1
1994
733
0.030
Why?
Age Factors
1
2018
1933
0.030
Why?
Platinum
1
2012
58
0.030
Why?
Aorta, Abdominal
2
1990
62
0.030
Why?
Phenotype
1
2019
2334
0.030
Why?
Organ Sparing Treatments
1
2011
39
0.030
Why?
Supraglottitis
1
2011
3
0.030
Why?
Length of Stay
1
1995
718
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
192
0.030
Why?
Glutamates
1
2011
94
0.030
Why?
Leucovorin
1
2010
220
0.030
Why?
Clinical Trials, Phase I as Topic
1
2011
150
0.030
Why?
Antimetabolites, Antineoplastic
1
2012
251
0.030
Why?
Osteoradionecrosis
1
2010
15
0.030
Why?
Guanine
1
2011
208
0.030
Why?
Antineoplastic Agents, Phytogenic
1
2012
298
0.020
Why?
Interferon-alpha
1
2010
241
0.020
Why?
Postoperative Period
1
2010
314
0.020
Why?
Laryngoscopy
1
2009
39
0.020
Why?
Camptothecin
1
2010
196
0.020
Why?
Siblings
1
2010
113
0.020
Why?
Deoxycytidine
1
2011
242
0.020
Why?
Treatment Failure
1
2010
307
0.020
Why?
Dose-Response Relationship, Radiation
1
2009
201
0.020
Why?
Transforming Growth Factor alpha
1
2009
52
0.020
Why?
Syndrome
1
2010
437
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
80
0.020
Why?
Postoperative Complications
1
1999
2316
0.020
Why?
Chi-Square Distribution
1
2009
385
0.020
Why?
Bone Marrow Cells
1
2010
261
0.020
Why?
Arteriosclerosis
1
1988
166
0.020
Why?
Hypersensitivity
1
2009
144
0.020
Why?
Recombinant Proteins
1
2010
1068
0.020
Why?
Bacterial Infections
1
2010
228
0.020
Why?
Neoplasm Metastasis
1
2012
1063
0.020
Why?
Lymphatic Metastasis
1
2009
508
0.020
Why?
Regression Analysis
1
2009
631
0.020
Why?
Autoantibodies
1
2008
263
0.020
Why?
Cranial Sinuses
1
2006
13
0.020
Why?
Odds Ratio
1
2008
694
0.020
Why?
Blood Vessel Prosthesis
1
1988
231
0.020
Why?
Neoplasm Proteins
1
2010
551
0.020
Why?
Comorbidity
1
2009
954
0.020
Why?
Endothelium, Vascular
1
1988
450
0.020
Why?
Cerebrovascular Circulation
1
2006
224
0.020
Why?
Prevalence
1
2008
1288
0.020
Why?
Coronary Artery Disease
1
1988
376
0.020
Why?
Preoperative Care
1
2006
418
0.020
Why?
Signal Transduction
1
2014
3337
0.020
Why?
Algorithms
1
2011
1858
0.010
Why?
Registries
1
2006
688
0.010
Why?
Asthma
1
2009
909
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
62
0.010
Why?
Case-Control Studies
1
2006
1839
0.010
Why?
Ticarcillin
1
1999
2
0.010
Why?
Mouthwashes
1
1999
5
0.010
Why?
Ampicillin
1
1999
29
0.010
Why?
Administration, Topical
1
1999
98
0.010
Why?
Injections, Intravenous
1
1999
270
0.010
Why?
Infant
2
1996
3163
0.010
Why?
Child, Preschool
2
1996
3820
0.010
Why?
Pilot Projects
1
1999
844
0.010
Why?
Suspensions
1
1996
8
0.010
Why?
Animals
2
1994
27411
0.010
Why?
Bacteria
1
1999
469
0.010
Why?
Acute Disease
1
1996
877
0.010
Why?
Back Pain
1
1990
37
0.010
Why?
Hematoma
1
1990
97
0.010
Why?
6-Ketoprostaglandin F1 alpha
1
1988
6
0.010
Why?
Polytetrafluoroethylene
1
1988
70
0.010
Why?
Microscopy, Electron, Scanning
1
1988
160
0.010
Why?
Jugular Veins
1
1988
76
0.010
Why?
Omentum
1
1988
70
0.010
Why?
Microcirculation
1
1988
114
0.010
Why?
Dogs
1
1988
811
0.010
Why?
Aorta
1
1988
299
0.000
Why?
Thrombosis
1
1988
279
0.000
Why?
Blair's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_